Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients

Type 2 diabetes mellitus (T2DM) is a persistent metabolic condition that contributes to the development of cardiovascular diseases. Numerous studies have provided evidence that individuals with T2DM are at a greater risk of developing cardiovascular diseases, typically two to four times more likely...

Descripción completa

Detalles Bibliográficos
Autores principales: Amalia, Muttia, Puteri, Meidi Utami, Saputri, Fadlina Chany, Sauriasari, Rani, Widyantoro, Bambang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381765/
https://www.ncbi.nlm.nih.gov/pubmed/37511848
http://dx.doi.org/10.3390/life13071473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381765/
https://www.ncbi.nlm.nih.gov/pubmed/37511848
http://dx.doi.org/10.3390/life13071473

Ejemplares similares